Last $44.76 USD
Change Today -0.50 / -1.10%
Volume 9.6M
ABT On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
London
Sao Paulo
Frankfurt
As of 8:04 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - abbott laboratories (ABT)

Name (Connections)Board RelationshipsTitleKey Developments
Roxanne Austin 64 RelationshipsDirector, Chairman of Audit Committee, Member of Executive Committee and Member of Compensation Committee 
Glenn Tilton 235 RelationshipsDirector, Member of Audit Committee and Member of Public Policy Committee 
Samuel Scott III 130 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee 
Edward Liddy 206 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee 
Nancy McKinstry 106 RelationshipsDirector, Member of Audit Committee and Member of Public Policy Committee 

Compensation Committee* - abbott laboratories (ABT)

Name (Connections)Board RelationshipsTitle
Roxanne Austin 64 RelationshipsDirector, Chairman of Audit Committee, Member of Executive Committee and Member of Compensation Committee
W. Farrell 321 RelationshipsDirector, Chairman of Compensation Committee, Member of Executive Committee and Member of Nominations & Governance Committee
Edward Liddy 206 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
William Osborn 92 RelationshipsLead Director, Chairman of Nominations & Governance Committee, Member of Executive Committee and Member of Compensation Committee
Samuel Scott III 130 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
ABT Compensation vs. Industry
Not meaningful
Chief Executive Officer
Not meaningful
Chief Financial Officer
Share price activity for ABBOTT LABORATORIES (ABT)
52 Week Price Performance
ABT
Industry Average

Nominating Committee* - abbott laboratories (ABT)

Name (Connections)Board RelationshipsTitleKey Developments
W. Farrell 321 RelationshipsDirector, Chairman of Compensation Committee, Member of Executive Committee and Member of Nominations & Governance CommitteeAbbott Laboratories Announces Board Changes
07/7/14
William Osborn 92 RelationshipsLead Director, Chairman of Nominations & Governance Committee, Member of Executive Committee and Member of Compensation CommitteeAbbott Laboratories Announces Retirement of Greg W. Linder as Vice President and Controller, Effective from February 28, 2013
07/13/12
Phebe Novakovic 20 RelationshipsDirector, Chairman of Public Policy Committee, Member of Executive Committee and Member of Nominations & Governance CommitteeAbbott Laboratories Announces Management Changes
06/1/12
Robert Alpern M.D. 60 RelationshipsDirector, Member of Public Policy Committee and Member of Nominations & Governance CommitteeEdward L. Michael, Executive Vice President, Diagnostics Products to Retire from Abbott Laboratories
05/2/12
Sally Blount Ph.D. 10 RelationshipsDirector, Member of Nominations & Governance Committee and Member of Public Policy CommitteeAbbott Laboratories Announces Director Appointments; Amends First Sentence of Article III, Section 2 of By-Laws
12/14/11

Corporate Governance Committee* - abbott laboratories (ABT)

Name (Connections)Board RelationshipsTitle
Robert Alpern M.D. 60 RelationshipsDirector, Chairman of Audit Committee, Member of Executive Committee and Member of Compensation Committee
Sally Blount Ph.D. 10 RelationshipsDirector, Chairman of Compensation Committee, Member of Executive Committee and Member of Nominations & Governance Committee
W. Farrell 321 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Phebe Novakovic 20 RelationshipsLead Director, Chairman of Nominations & Governance Committee, Member of Executive Committee and Member of Compensation Committee
William Osborn 92 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
ABT and Competitor
Insiders vs. External
Board
9%
91%
Abbott Laboratories
14%
86%
Actavis plc
10%
90%
Danaher Corp.
13%
87%
Eli Lilly and Company
7%
93%
Teva Pharmaceutical Industries Limited
11%
89%
AbbVie Inc.
Insiders
External Board Members

Executive Committee* - abbott laboratories (ABT)

Name (Connections)Board RelationshipsTitle
Roxanne Austin 64 RelationshipsDirector, Chairman of Audit Committee, Member of Executive Committee and Member of Compensation Committee
W. Farrell 321 RelationshipsDirector, Chairman of Compensation Committee, Member of Executive Committee and Member of Nominations & Governance Committee
H. Fuller 16 RelationshipsFormer Lead Director
Jack Greenberg J.D. 306 RelationshipsFormer Director, Chairman of Audit Committee and Member of Executive Committee
Phebe Novakovic 20 RelationshipsDirector, Chairman of Public Policy Committee, Member of Executive Committee and Member of Nominations & Governance Committee
William Osborn 92 RelationshipsLead Director, Chairman of Nominations & Governance Committee, Member of Executive Committee and Member of Compensation Committee
W. Reynolds Ph.D. 15 RelationshipsFormer Director, Chairman of Public Policy Committee, Member of Executive Committee and Member of Nominations & Governance Committee
Roy Roberts 32 RelationshipsFormer Director, Chairman of Public Policy Committee, Member of Executive Committee and Member of Nominations & Governance Committee
William Smithburg 19 RelationshipsFormer Director, Chairman of Compensation Committee, Member of Executive Committee and Member of Audit Committee
Miles White 109 RelationshipsChairman, Chief Executive Officer and Chairman of Executive Committee
Management Effectiveness Relative to the Industry
Return on Equity
0.9x
Return on Assets
0.4x
Return on Total Capital
0.5x
TEV/Total Revenue(LTM)
0.5x
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:US $44.76 USD -0.50

ABT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $60.35 USD -2.77
Actavis plc $266.54 USD -6.71
Danaher Corp $82.38 USD -1.55
Eli Lilly & Co $72.00 USD -0.11
Teva Pharmaceutical Industries Ltd $56.86 USD -0.70
View Industry Companies
 

Industry Analysis

ABT

Industry Average

Valuation ABT Industry Range
Price/Earnings 39.7x
Price/Sales 3.4x
Price/Book -- Not Meaningful
Price/Cash Flow 23.7x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.